UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM S-8

             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

                     MEDICAL TECHNOLOGY & INNOVATIONS, INC.
             ------------------------------------------------------
                 (Name of small business issuer in its charter)


         FLORIDA                                                65-2954561
- -----------------------------                           ----------------------
(State or other jurisdiction                              (I.R.S. Employer or
of incorporation organization)                               Identification No.)


3725 Investment Lane, Riviera Beach, FL                            33404
---------------------------------------------             ----------------------
(Address of principal place of business)                          (zip code)


                     Medical Technology & Innovations, Inc.
                  Year 2000 Consultant Stock Compensation Plan
             ------------------------------------------------------
                            (Full title of the plan)

                            Donald F. Mintmire, Esq.,
                         265 Sunrise Avenue, Suite 204,
                              Palm Beach, FL 33480
                               Tel: (561) 832-5696
           -----------------------------------------------------------
            (Name, address and telephone number of agent for service)


                         CALCULATION OF REGISTRATION FEE

                                 PROPOSED        MAXIMUM
 TITLE OF        PROPOSED        MAXIMUM        AGGREGATE
SECURITIES        AMOUNT        OFFERING        OFFERING       AMOUNT OF
 TO BE             TO BE           PRICE          PRICE        REGISTRATION
REGISTERED      REGISTERED       PER SHARE      PER SHARE        FEE (1)
-------------  -------------   -------------  --------------   ------------
Common Stock    6,500,000         $0.125           812,500        $214.50
No par



<PAGE>



(1)  Estimated  pursuant  to Rule  457(c) and 457(h)  solely for the  purpose of
calculating  the  Registration  Fee, which is based on the closing sale price of
the  Company's  Common  Stock on June 9, 2000 as reported on the OTC  Electronic
Bulletin Board.

(2)  Represents  the  maximum  number of shares to which  options may be granted
under the Medical Technology & Innovations,  Inc.  Consultant Stock Compensation
Plan (the "Plan").


                                     PART II

                 INFORMATION REQUIRED IN REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference

     The  following   documents  which  have  been  heretofore  filed  with  the
Securities and Exchange Commission (the "Commission") by the Registrant pursuant
to the Securities  Exchange Act of 1934 (the "Exchange Act") are incorporated by
reference in this Registration Statement:

     (1) The Registrant's Annual Report on Form l0-KSB for the fiscal year ended
June 30, 1999;

     (2) All other reports filed by the Registrant with the Commission  pursuant
to  Section  13(a) or  Section  15(d) of the  Exchange  Act since the end of the
fiscal year covered by the Registrant's Annual Report referred to above; and

     (3) The description of the Common Stock of the Registrant  contained in the
Registran's Registration Statement.

         All documents filed by the Registrant  with the Commission  pursuant to
Section 13(a),  13(c), 14 or 15(d) of the Exchange Act subsequent to the date of
this  Registration  Statement  and  prior  to  the  filing  of a  post-effective
amendment  hereto which indicates that all securities  offered have been sold or
which  deregisters all securities then remaining  unsold,  shall be deemed to be
incorporated by reference herein and to be a part hereof from the date of filing
of such docum nts.

Item 4. Description of Securities.

         Not applicable.

Item 5. Interests of Named Experts and Counsel.

         Not applicable.

Item 6. Indemnification of Directors and Officers.

     The Bylaws of the  Registrant  contain  provisions  which  provide  for the
indemnification  of directors,  officers,  and other  employees or agents of the
Registrant  properly appointed to serve in an official capacity who while acting
in good faith, in the best interests of the Registrant,  and within the scope of


<PAGE>



their offices, are or are threatened to be named as a defendant or respondent in
a civil or  criminal  action.  The extent of the  indemnification  is limited to
judgements,  penalties,  fines,  settlements  and reasonable  expenses  actually
incurred.

Item 7. Exemption from Registration Claimed.

         Not applicable.

Item 8.   Exhibits.

*         5.1     Opinion of Mintmire & Associates

*         10.1    Medical Technology & Innovations, Inc., Year 2000 Consultant
                  Stock Compensation Plan

*         23.1    Consent of Simon Lever & Company

          23.2    Consent of Mintmire & Associates  (contained in the opinion
                  filed as Exhibit 5.1 hereof)
----------------------------
(* filed herewith)

Item 9. Undertakings.

The Registrant hereby undertakes:

(a)       (1) to file, during any period in which it offers or sells securities,
a post effective amendment  to  this  registration   statement  to  include  any
prospectus required by Section 10(a) (3) of the Securities Act;

          (2) that,  for the  purpose  of  determining  any  liability under the
Securities  Act  of  1933,  to  treat  each  post-effective  amendment  as a new
registration  statement  of the  securities  offered,  and the  offering  of the
securities at that time to be the initial bona fide offering;

          (3) to remove from registration by means of a post-effective amendment
any of the securities that remain unsold at the end of the offering.

         Insofar as indemnification for liabilities arising under the Securities
Act of 1933 (the "Act") may be permitted to directors, officers, and controlling
persons of the small business  issuer pursuant to the foregoing  provisions,  or
otherwise, the small business issuer has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy
as expressed in the Act and is,  therefore,  unenforceable.  In the event that a
claim for  indemnification  against such liabilities  (other than the payment by
the Company in the  successful  defense of any action,  suit or  proceeding)  is
asserted by such director,  officer or controlling person in connection with the
securities  being  registered,  the Company will,  unless in the opinion of this
counsel that matter has been settled by controlling precedent, submit to a court
of appropriate  jurisdiction the question whether such  indemnification by it is
against  public policy as expressed in the Act and will be governed by the final
jurisdiction of such issue.


<PAGE>




                                   SIGNATURES

Pursuant to the  requirements  of the  Securities  Act of 1933,  the  registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement to be signed on its behalf, in the City of Riviera Beach,  Florida, on
June , 2000.

                                      MEDICAL TECHNOLOGY & INNOVATIONS, INC.

                                       By:     /s/ Jeremy Feakins
                                                ---------------------------
                                                Jeremy Feakins
                                                CEO

Pursuant to the  requirements of the Securities Act of 1933,  this  registration
statement has been signed by the following  persons in the capacities and on the
dates indicated.


   Signature                     Title                          Date
-------------------------        -------------------        -------------------


/s/ Jeremy Feakins
-------------------------        CEO, Director              June 9, 2000
Jeremy Feakins

/s/ Joseph DelVecchio
---------------------------      Executive Vice Pres.       June 9, 2000
                                 COO, Director

/s/ Dennis Surovcik
-------------------------        Secretary                  June 9, 2000
Dennis Surovcik                  Director


/s/ Mathew Crimmins
-------------------------                                   June 9, 2000
Mathew Crimmins                  Director
[{"type": "S-8", "sequence": "1", "filename": "0001.txt", "description": "1933 REGISTRATION STATEMENT", "secsgml_size_bytes": 8660}]
{"company-data": {"conformed-name": "MEDICAL TECHNOLOGY & INNOVATIONS INC /FL/", "cik": "0000847464", "assigned-sic": "7900", "irs-number": "652954561", "state-of-incorporation": "FL", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-39686", "film-number": "657572"}, "business-address": {"street1": "615 CENTERVILLE ROAD", "city": "LANCASTER", "state": "PA", "zip": "17601", "phone": "7178926770"}, "mail-address": {"street1": "615 CENTERVILLE ROAD", "city": "LANCASTER", "state": "PA", "zip": "17601"}}
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM S-8

             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

                     MEDICAL TECHNOLOGY & INNOVATIONS, INC.
             ------------------------------------------------------
                 (Name of small business issuer in its charter)

         FLORIDA                                                65-2954561
- -----------------------------                           ----------------------
(State or other jurisdiction                              (I.R.S. Employer or
of incorporation organization)                               Identification No.)

3725 Investment Lane, Riviera Beach, FL                            33404
---------------------------------------------             ----------------------
(Address of principal place of business)                          (zip code)

                     Medical Technology & Innovations, Inc.
                  Year 2000 Consultant Stock Compensation Plan
             ------------------------------------------------------
                            (Full title of the plan)

                            Donald F. Mintmire, Esq.,
                         265 Sunrise Avenue, Suite 204,
                              Palm Beach, FL 33480
                               Tel: (561) 832-5696
           -----------------------------------------------------------
            (Name, address and telephone number of agent for service)

                         CALCULATION OF REGISTRATION FEE

                                 PROPOSED        MAXIMUM
 TITLE OF        PROPOSED        MAXIMUM        AGGREGATE
SECURITIES        AMOUNT        OFFERING        OFFERING       AMOUNT OF
 TO BE             TO BE           PRICE          PRICE        REGISTRATION
REGISTERED      REGISTERED       PER SHARE      PER SHARE        FEE (1)
-------------  -------------   -------------  --------------   ------------
Common Stock    6,500,000         $0.125           812,500        $214.50
No par
(1)  Estimated  pursuant  to Rule  457(c) and 457(h)  solely for the  purpose of
calculating  the  Registration  Fee, which is based on the closing sale price of
the  Company's  Common  Stock on June 9, 2000 as reported on the OTC  Electronic
Bulletin Board.

(2)  Represents  the  maximum  number of shares to which  options may be granted
under the Medical Technology & Innovations,  Inc.  Consultant Stock Compensation
Plan (the "Plan").

                                     PART II

                 INFORMATION REQUIRED IN REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference

     The  following   documents  which  have  been  heretofore  filed  with  the
Securities and Exchange Commission (the "Commission") by the Registrant pursuant
to the Securities  Exchange Act of 1934 (the "Exchange Act") are incorporated by
reference in this Registration Statement:

     (1) The Registrant's Annual Report on Form l0-KSB for the fiscal year ended
June 30, 1999;

     (2) All other reports filed by the Registrant with the Commission  pursuant
to  Section  13(a) or  Section  15(d) of the  Exchange  Act since the end of the
fiscal year covered by the Registrant's Annual Report referred to above; and

     (3) The description of the Common Stock of the Registrant  contained in the
Registran's Registration Statement.

         All documents filed by the Registrant  with the Commission  pursuant to
Section 13(a),  13(c), 14 or 15(d) of the Exchange Act subsequent to the date of
this  Registration  Statement  and  prior  to  the  filing  of a  post-effective
amendment  hereto which indicates that all securities  offered have been sold or
which  deregisters all securities then remaining  unsold,  shall be deemed to be
incorporated by reference herein and to be a part hereof from the date of filing
of such docum nts.

Item 4. Description of Securities.

         Not applicable.

Item 5. Interests of Named Experts and Counsel.

         Not applicable.

Item 6. Indemnification of Directors and Officers.

     The Bylaws of the  Registrant  contain  provisions  which  provide  for the
indemnification  of directors,  officers,  and other  employees or agents of the
Registrant  properly appointed to serve in an official capacity who while acting
in good faith, in the best interests of the Registrant,  and within the scope of
their offices, are or are threatened to be named as a defendant or respondent in
a civil or  criminal  action.  The extent of the  indemnification  is limited to
judgements,  penalties,  fines,  settlements  and reasonable  expenses  actually
incurred.

Item 7. Exemption from Registration Claimed.

         Not applicable.

Item 8.   Exhibits.

*         5.1     Opinion of Mintmire & Associates

*         10.1    Medical Technology & Innovations, Inc., Year 2000 Consultant
                  Stock Compensation Plan

*         23.1    Consent of Simon Lever & Company

          23.2    Consent of Mintmire & Associates  (contained in the opinion
                  filed as Exhibit 5.1 hereof)
----------------------------
(* filed herewith)

Item 9. Undertakings.

The Registrant hereby undertakes:

(a)       (1) to file, during any period in which it offers or sells securities,
a post effective amendment  to  this  registration   statement  to  include  any
prospectus required by Section 10(a) (3) of the Securities Act;

          (2) that,  for the  purpose  of  determining  any  liability under the
Securities  Act  of  1933,  to  treat  each  post-effective  amendment  as a new
registration  statement  of the  securities  offered,  and the  offering  of the
securities at that time to be the initial bona fide offering;

          (3) to remove from registration by means of a post-effective amendment
any of the securities that remain unsold at the end of the offering.

         Insofar as indemnification for liabilities arising under the Securities
Act of 1933 (the "Act") may be permitted to directors, officers, and controlling
persons of the small business  issuer pursuant to the foregoing  provisions,  or
otherwise, the small business issuer has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy
as expressed in the Act and is,  therefore,  unenforceable.  In the event that a
claim for  indemnification  against such liabilities  (other than the payment by
the Company in the  successful  defense of any action,  suit or  proceeding)  is
asserted by such director,  officer or controlling person in connection with the
securities  being  registered,  the Company will,  unless in the opinion of this
counsel that matter has been settled by controlling precedent, submit to a court
of appropriate  jurisdiction the question whether such  indemnification by it is
against  public policy as expressed in the Act and will be governed by the final
jurisdiction of such issue.
SIGNATURES

Pursuant to the  requirements  of the  Securities  Act of 1933,  the  registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement to be signed on its behalf, in the City of Riviera Beach,  Florida, on
June , 2000.

                                      MEDICAL TECHNOLOGY & INNOVATIONS, INC.

                                       By:     /s/ Jeremy Feakins
                                                ---------------------------
                                                Jeremy Feakins
                                                CEO

Pursuant to the  requirements of the Securities Act of 1933,  this  registration
statement has been signed by the following  persons in the capacities and on the
dates indicated.

   Signature                     Title                          Date
-------------------------        -------------------        -------------------

/s/ Jeremy Feakins
-------------------------        CEO, Director              June 9, 2000
Jeremy Feakins

/s/ Joseph DelVecchio
---------------------------      Executive Vice Pres.       June 9, 2000
                                 COO, Director

/s/ Dennis Surovcik
-------------------------        Secretary                  June 9, 2000
Dennis Surovcik                  Director

/s/ Mathew Crimmins
-------------------------                                   June 9, 2000
Mathew Crimmins                  Director